| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.43 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.49 | 0.004 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |